The Claim
Daily supplementation with 30 billion live cells of Pasteurized Akkermansia muciniphila MucT for 4 months has no significant effect on whole-body insulin sensitivity in adults with metabolic syndrome, as measured by the Matsuda index.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking a specific type of pasteurized bacteria daily for four months does not change how well the body uses insulin in adults with metabolic syndrome.
See the scientific wording
Pasteurized Akkermansia muciniphila MucT supplementation does not significantly improve whole-body insulin sensitivity in the general population of adults with metabolic syndrome, as measured by the Matsuda index after 4 months of daily 30 billion cell administration, indicating a lack of broad efficacy.
The supplement releases two stable proteins that act on the gut: one triggers cells to release a hormone that tells the pancreas to release more insulin, and the other strengthens the gut lining so fewer inflammatory molecules leak into the blood. This reduces fat inflammation and helps the body use insulin better, but only in people whose gut had very little of this bacteria to begin with.
What the research says
1 studyTaking this supplement didn't help most people with metabolic syndrome use insulin better, which is what the claim says. But it did help some people who started with very low levels of this bacteria.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.